Clinical Trial Update: Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating Entresto’s effect on the sympathetic nervous system in heart failure patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Heart Failure | Phase 4 | Status: TERMINATED